Haoxi Health Technology Limited (NASDAQ:HAO) Short Interest Down 17.4% in December

Haoxi Health Technology Limited (NASDAQ:HAO) saw a large decline in short interest during the month of December. As of December 31st, there was short interest totaling 73,787 shares, a decline of 17.4% from the December 15th total of 89,321 shares. Approximately 0.9% of the company’s stock are short sold. Based on an average daily volume of 16,141 shares, the short-interest ratio is currently 4.6 days. Based on an average daily volume of 16,141 shares, the short-interest ratio is currently 4.6 days. Approximately 0.9% of the company’s stock are short sold.

Haoxi Health Technology Stock Performance

Haoxi Health Technology stock opened at $1.56 on Wednesday. The company has a quick ratio of 5.05, a current ratio of 5.05 and a debt-to-equity ratio of 0.02. Haoxi Health Technology has a 12 month low of $0.82 and a 12 month high of $4.00. The company has a fifty day moving average price of $1.09 and a two-hundred day moving average price of $1.18.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of Haoxi Health Technology in a research note on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, Haoxi Health Technology currently has an average rating of “Sell”.

About Haoxi Health Technology

Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. It offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms. The company places its ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, and Sina Weibo.